Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT04817969

Persona Ti-Nidium Post-Market Clinical Follow-up

Persona® Ti-Nidium® Personalized Total Knee System A Post-Market Clinical Follow-up Study to Provide Safety, Performance and Clinical Benefits Data Using the Persona Ti-Nidium Total Knee System and Instrumentation

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
240 (estimated)
Sponsor
Zimmer Biomet · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The main objectives of this study are to evaluate overall clinical performance and safety of the Persona Ti-Nidium implant in total knee arthroplasty.

Detailed description

The study design is a prospective, multicenter data collection model of the 510(k) cleared Persona Ti-Nidium Total Knee System. The study will require each site to obtain institutional review board (IRB) approval prior to study enrollment. All potential study subjects will be required to participate in the Informed Consent Process. All study subjects will undergo preoperative clinical evaluations prior to their total knee arthroplasty. Investigators will collect clinical data for a required 10 years. Follow-up clinical visits include Early Post-op, 6 months, 1 year, 2, 3, 5, 7 and 10 years post-operatively. The objective of this study is to evaluate clinical performance, benefits and safety of the Persona Ti-Nidium implant in total knee arthroplasty. Specific assessments include: 1. Confirming the long-term safety, performance and clinical benefits of the Persona Ti-Nidium total knee system and instrumentation in primary and revision TKA. 2. Verifying that, under normal use, the performance and clinical benefits of this device and its instrumentation conform to those intended by the manufacturer by recording patient-reported clinical outcomes measures (PROMs) and radiographic outcomes (if available).

Conditions

Interventions

TypeNameDescription
DEVICEZimmer Biomet Persona Ti-Nidium Total Knee SystemPrimary Knee Total Arthroplasty

Timeline

Start date
2021-06-01
Primary completion
2034-05-01
Completion
2034-05-01
First posted
2021-03-26
Last updated
2025-10-24

Locations

7 sites across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT04817969. Inclusion in this directory is not an endorsement.